Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities.
about
Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrierPerspectives of nanotechnology in minimally invasive therapy of breast cancerNANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?Unique growth pattern of human mammary epithelial cells induced by polymeric nanoparticlesEnhancing Tumor Penetration of Nanomedicines.Multicellular tumor spheroids as a model for assessing delivery of oligonucleotides in three dimensionsActive targeting of mesoporous silica drug carriers enhances γ-secretase inhibitor efficacy in an in vivo model for breast cancer.Perylene-diimide-based nanoparticles as highly efficient photoacoustic agents for deep brain tumor imaging in living mice.Vectors for inhaled gene therapy in lung cancer. Application for nano oncology and safety of bio nanotechnology.New photodynamic therapy with next-generation photosensitizers.Comparison of nanoparticle penetration into solid tumors and sites of inflammation: studies using targeted and nontargeted liposomesTargeted nanotheranostics for personalized cancer therapy.Recent advances in intracellular and in vivo ROS sensing: focus on nanoparticle and nanotube applications.Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery.Liposomal delivery and polyethylene glycol-liposomal oxaliplatin for the treatment of colorectal cancer (Review).Macrophages associated with tumors as potential targets and therapeutic intermediates.Nanomedicine: a pharma perspective.Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting.Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs.Thermally triggered theranostics for pancreatic cancer therapy.Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy.Synthesis and In Vitro Evaluation of Polyethylene Glycol-Paclitaxel Conjugates for Lung Cancer Therapy.Photoluminescent carbon nanotubes interrogate the permeability of multicellular tumor spheroids.Effects of PEGylated paclitaxel nanocrystals on breast cancer and its lung metastasis.Biodegradable polymeric micelles encapsulated JK184 suppress tumor growth through inhibiting Hedgehog signaling pathway.The Tumor Microenvironment as a Barrier to Cancer Nanotherapy.The antitumor effect of a new docetaxel-loaded microbubble combined with low-frequency ultrasound in vitro: preparation and parameter analysis.Enhancing regenerative approaches with nanoparticles.Gum arabic-coated radioactive gold nanoparticles cause no short-term local or systemic toxicity in the clinically relevant canine model of prostate cancer.Mechanisms of cooperation in cancer nanomedicine: towards systems nanotechnology.Recombinant Immunotoxin Therapy of Solid Tumors: Challenges and Strategies.Multilayered Magnetic Nanobeads for the Delivery of Peptides Molecules Triggered by Intracellular Proteases.Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma.Sustained delivery of vincristine inside an orthotopic mouse sarcoma model decreases tumor growth.A Computational/Experimental Assessment of Antitumor Activity of Polymer Nanoassemblies for pH-Controlled Drug Delivery to Primary and Metastatic Tumors.Differential uptake of nanoparticles by human M1 and M2 polarized macrophages: protein corona as a critical determinant.Synergistic cytotoxicity of the poly (ADP-ribose) polymerase inhibitor ABT-888 and temozolomide in dual-drug targeted magnetic nanoparticles.Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.Bioresponsive and near infrared photon co-enhanced cancer theranostic based on upconversion nanocapsules.Dual-drug nanomedicine with hydrophilic F127-modified magnetic nanocarriers assembled in amphiphilic gelatin for enhanced penetration and drug delivery in deep tumor tissue.
P2860
Q26801300-E20895D0-6732-4120-BC75-E590E02AD902Q26828806-4B431949-62DF-4A56-B587-9BE72837791BQ28078448-8136C71B-2107-422E-8E72-792AC04955B1Q28391186-0442A874-9C65-4651-AC44-2633F9D33CDDQ30356887-741410A1-BC16-4CA6-9AF4-11372E8CFD0BQ33637214-E5B19EF0-09E5-449E-A1EE-D6019FD1AA3CQ34881011-5552BD24-4014-4951-BFF4-A3FB633745C7Q35141495-37CB63EA-6253-40A3-AD4D-41728FB97FA1Q36321710-A69949FB-7999-4367-B66C-82405404C1E5Q36405909-8A2C89EE-BE46-4182-BD25-AF5E051F21CCQ37013422-60239D40-6626-4CED-88BC-B36D74A0729CQ38054793-7915ACFC-DF58-4BEC-91E9-C3028641DCFCQ38056489-51AC9199-CAAF-4839-BF61-00ED8583A507Q38151736-CE3EB27C-6353-48D2-BFC9-E78EC4947097Q38205769-2BD6893A-E3B4-4E27-8B62-B3FCC74EFF61Q38211726-710848E2-3BD4-4512-954F-2180C1D30BE6Q38246663-C5FB269A-F914-4512-A05E-AD9F9491084FQ38403588-DC953D3B-46BE-434F-A991-4D7D8B14017CQ38406190-A30BF562-2B42-485E-9A27-61202FE77452Q38638795-2A33206B-49FC-4642-B28A-727C63F788F7Q38776676-50EC4345-BE38-48F9-BE95-02A32FE939C1Q38785747-652E6B51-A3FA-4895-928E-6476A7208296Q38828737-57921FE7-E1F3-48F6-9739-CD049916A678Q38868069-D1C4DDC6-A23A-46E2-87D9-4835FDE2388DQ38920722-EBD1C2A5-9F39-449D-8658-B0A50B78C39BQ38980088-C6AF7747-6437-496A-865D-0B5E7FB5DD71Q39192903-8BF4F4C6-0316-4B37-A8C2-5ADB43BF0308Q39239110-DE391D8A-98FD-483B-8EE3-AD866B0C2964Q41990210-C7FF5578-E817-4A54-89A2-AC96829037D6Q42145728-487AAA22-A5B7-421E-971A-02C2AE788BADQ42939121-E2DA3915-22E3-414E-AC32-467C862A0EC9Q47707286-16C38A72-B6E9-47A5-9560-AF0D4865FED0Q48012324-52444C04-2B57-478B-A83F-1F0C588CB185Q49023233-9EFA32B0-86D7-4378-B9F0-F2B1A265BD03Q50619364-97D5769A-9724-4DAC-B14E-20F1023F4301Q51363706-88E19775-10B6-459A-BE07-AE979374096DQ51735700-D7961C0F-3F01-4443-A3A8-A3F42421021CQ52719561-486E735B-D34E-4C1B-AD94-041BF0BB7C23Q55153242-060D8312-131F-455A-B2D7-EAB87EC12037Q55393640-09F71D21-41F9-4D0C-A61E-5B732CC1558B
P2860
Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Nanoscale drug delivery system ...... nt progress and opportunities.
@ast
Nanoscale drug delivery system ...... nt progress and opportunities.
@en
type
label
Nanoscale drug delivery system ...... nt progress and opportunities.
@ast
Nanoscale drug delivery system ...... nt progress and opportunities.
@en
prefLabel
Nanoscale drug delivery system ...... nt progress and opportunities.
@ast
Nanoscale drug delivery system ...... nt progress and opportunities.
@en
P2860
P1476
Nanoscale drug delivery system ...... nt progress and opportunities.
@en
P2093
Carolyn L Waite
Charles M Roth
P2860
P356
10.1615/CRITREVBIOMEDENG.V40.I1.20
P577
2012-01-01T00:00:00Z